Comparison of 18-FDG PET and CT for pretherapeutic staging of malignant lymphoma;Vergleich der Befunde von 18-FDG-PET und CT beim pratherapeutischen staging maligner lymphome

NuklearMedizin

Volumn 36, Issue 7, 1997, Pages 234-239

  Thill, R ^a,b   Neuerburg, J ^a   Fabry, U ^a   Cremerius, U ^a   Wagenknecht, G ^a   Hellwig, D ^a   Osieka, R ^a   Gunther R ^a   Bull U ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

FDG PET; Lymphoma; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LYMPHOMA; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY;

EID: 0030670656     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1629839     Document Type: Article

References (22)

1. Bares R, Galonka P, Dempke W, Hand St, Büll U, Osieka R. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron emission tomography. In: Somatostatin Receptor Imaging. Hormone and Metabolic Research; Suppl Vol. 27. Bihl H, Dörr U (eds). Stuttgart: Thieme 1995; pp. 56-8.
2. Bares R, Horstmann K, Altehoefer C et al. F-18 Deoxyglucose (FDG) PET zur Vitalitätsbeurteilung maligner Lymphome nach Radiatio und/oder Chemotherapie. Nuklearmedizin 1991; 30: A23.
3. Callen PW, Korobkin M, Isherwood I. Computed tomographic evaluation of the retrocrural prevertebral space. Am J Roentgenol 1977; 129: 907-10.
4. Cremerius U, Thill R, Bares R, Dohmen BM, Sabri O, Osieka R, Büll U. Quantitative Kriterien durch FDG-PET für die Verlaufskontrolle maligner Lymphome. Nuklearmedizin 1996; 35: A27.
5. HD-7 Protokoll der Deutschen Hodgkin-Studiengruppe. Diehl V (Hrsg.). Universitätsklinik Köln 1994; 23.
6. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H et al. Evaluations of tumour metabolism and multidrug resistance in patients with malignant lymphomas. Eur J Nucl 1995; 22: 434-42.
7. Dohmen B, Bares R, Fabry U, Osieka R, Bull U. Intratumorale MIBI-Speicherung als prognostischer Marker vor Chemotherapie. Nuklearmedizin 1995; 34: A119.
8. Front D, Bar-Shalum R, Epelbaum R et al. Early detection of lymphoma recurrence by gallium-67 tomography. J Nucl Med 1993; 34: 2101-4.
9. Genereux GP, Howie JL. Normal mediastinal lymph node size and number: CT and anatomic study. Am J Roentgenol 1984; 142: 1095-100.
10. Kostakogu L, Yeh SDJ, Portlock C et al. Validation of gallium-67-citrate single-photon emission computed tomography in biopsyconfirmed residual Hodgkin's disease in the mediastinum. J Nucl Med 1992; 33: 345-50.
11. Leskinnen-Kallio S, Ruotsalainen U, Nagren K, Teras M, Joensuu H. Uptake of Carbon-11-Methionine and Fluorodeoxyglucose in Non-Hodgkin's Lymphoma: a PET study. J Nucl Med 1991; 32: 1211-8.
12. Lipp RW, Silly H, Ranner G et al. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med 1995; 36: 13-8.
13. Mancuso AA, Maceri D, Rice D, Hanafee W. CT of cervical lymph node cancer. Am J Roentgenol 1981; 136: 381-5.
14. Minn H, Leskinen-Kallio S, Lindholm P, Bergman J, Ruotsalainen U, Teras M, Haaparanta M. [18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin. J comput assist Tomogr 1993; 17: 115-23.
15. Hellwig D. Verfahren zur Korrektur des Partial-Volumen-Effektes bei der Positronen-Emissions-Tomographie. Diplomarbeit, RWTH Aachen. 1992.
16. Newman JS, Francis IR, Kaminski MS, Wahl RL. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190: 111-6.
17. Okada J, Oonishi H, Yoshikawa K, Itami J, Uno K. Imaseki K, Arimizu N. FDG-PET for predicting the prognosis of malignant lymphoma. Ann Nucl Med 1994; 8: 187-91.
18. Schaadt M, Diehl V. Maligne Lymphome. In: Innere Medizin. Classen M, Diehl V, Kochsiek K (Hrsg.). München: Urban und Schwarzenberg 1991; 135 ff.
19. Schomburg A, Bender H, Reichel C, Sommer T, Ruhlmann J, Kozak B, Biersack H. Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures. Eur J Nucl Med 1996; 23: 571-4.
20. Thill R, Cremerius U, Sabri O, Wagenknecht G, Hellwig D, Osieka R, Bull U. Quantitative criteria in 18-FDG-PET for malignant lymphoma to evaluate cytostatic therapy. A follow-up study. In: Proc Europ Conf Research and Application of PET in Oncology. Paaus AMS, Pruim J, Franssen EJF, Vaalburg W (eds). Groningen: Academisch Ziekenhuis 1996; 12-4.
21. Tumeh S, Rosenthal DS, Kaplan WD, English RJ, Holman BL. Lymphoma: evaluation with Ga-67 SPECT. Radiology 1987; 164: 111-4.
22. Ziegels P, Nocaudie M, Huglo D, Deveaux M et al. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 scanning in the assessment of lymphomas. Eur J Nucl 1995, 22: 126-31.